Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Unlike full-length GH, which binds to growth hormone receptors and triggers IGF-1 production, AOD-9604 appears to work through alternative cellular mechanisms
Limitations Direct clinical evidence for this specific molecule is limited
The results of early clinical trials with ARO-ANG3 demonstrated reductions in circulating levels of ANGPTL3 of up to 84%, reductions in circulating triglyceride levels of up to 58%, and reductions of non-HDL cholesterol of up to 26%
Lipid Metabolism Cancer Life (Basel)
Nausea, vomiting, diarrhea, and constipation are the most frequently reported issues with both peptides
A meta-analysis of more than 30 trials found that the overall remission rate of MALT lymphomas with a low histological grade that is restricted to the perigastric lymph nodes or the gastric wall (stage I or stage IIe 1 illness) was 78% (107)
